Granulomatosis Infantiseptica

What is Granulomatosis infantiseptica?

Granulomatosis infantiseptica is a severe form of neonatal listeriosis involving disseminated granulomatous lesions in the skin and internal organs after in utero exposure to Listeria monocytogenes. This condition typically follows maternal infection with transplacental spread to the fetus. Symptoms appear within hours or days of birth, reflecting a systemic inflammatory response. While rare, these cases carry high mortality without immediate recognition and aggressive therapy.

What causes Granulomatosis infantiseptica?

The cause of granulomatosis infantiseptica is the vertical transmission of Listeria monocytogenes through an infected placenta. Maternal risk factors include the ingestion of contaminated deli meats or unpasteurized dairy products. Once the pathogen enters the maternal bloodstream, it can cross the placental barrier and seed fetal tissues. Fetal infection may cause disseminated microabscesses or granulomas and may be associated with chorioamnionitis, preterm labor, neonatal sepsis, or stillbirth.

What are the signs and symptoms of Granulomatosis infantiseptica?

Granulomatosis infantiseptica symptoms manifest as early-onset neonatal listeriosis, with signs of sepsis such as poor feeding, lethargy, temperature instability, apnea, bradycardia, and respiratory distress. Hepatosplenomegaly (an enlargement of the liver and spleen) is common and may occur with jaundice and thrombocytopenia (low platelet count).

A distinct granulomatosis infantiseptica rash often serves as a primary diagnostic clue. When present, the rash appears as an erythematous eruption with small pale nodules or granulomas. Within the first few hours or days of life, many cases exhibit signs of bacterial pneumonia, meningitis, or sepsis, reflecting disseminated neonatal listeriosis.

How is Granulomatosis infantiseptica diagnosed?

Diagnosis relies on isolating Listeria from sterile sites through blood and cerebrospinal fluid (CSF) cultures. Placental pathology can support the diagnosis by showing findings such as microabscesses, chorioamnionitis, or villitis (inflammation of the placental villi). PCR assays can provide rapid identification of the pathogen to guide immediate targeted therapy. Additional studies, such as chest imaging or CT/MRI, may be used when pneumonia or focal organ involvement is suspected. Because these signs overlap with other neonatal infections, clinicians must maintain a high index of suspicion.

How is Granulomatosis infantiseptica treated?

Management begins with empirical administration of ampicillin and gentamicin to cover Listeria and common Gram-negative organisms. The duration of therapy is typically about 14 days, or longer if meningitis or other complications are present. Supportive care may include respiratory support, fluid and electrolyte management, nutritional support, and cardiovascular support. If maternal infection is recognized before delivery, the pregnant patient should also be evaluated and treated.

What are the most important facts to know about Granulomatosis infantiseptica?

• Granulomatosis infantiseptica is a rare, life-threatening neonatal sepsis caused by intrauterine exposure to Listeria monocytogenes.
• It is due to vertical transmission via the placenta, often following maternal consumption of contaminated foods.
• Characteristic granulomatosis infantiseptica symptoms include acute respiratory distress, hepatosplenomegaly, and jaundice.
• A characteristic rash with erythematous papules, pustules, or nodules may appear on the skin.
• Diagnosis relies on culture or PCR testing of blood, CSF, placental material, or infected neonatal tissues when available, while treatment is based on ampicillin plus gentamicin.